BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25594142)

  • 21. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.
    Cantrell LA; Mendivil A; Gehrig PA; Boggess JF
    Gynecol Oncol; 2010 May; 117(2):260-5. PubMed ID: 20153886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis.
    Hellström AC; Sigurjonson T; Pettersson F
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):152-7. PubMed ID: 11167211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified radical hysterectomy in the treatment of early squamous cervical cancer.
    Magrina JF; Goodrich MA; Lidner TK; Weaver AL; Cornella JL; Podratz KC
    Gynecol Oncol; 1999 Feb; 72(2):183-6. PubMed ID: 10021298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
    van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
    Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive surgical management of early-stage cervical cancer: an analysis of the risk factors of surgical complications and of oncologic outcomes.
    Garabedian C; Merlot B; Bresson L; Tresch E; Narducci F; Leblanc E
    Int J Gynecol Cancer; 2015 May; 25(4):714-21. PubMed ID: 25647258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer.
    Khatib G; Küçükgöz Güleç Ü; Bariş Güzel A; Uygur B; Seydaoğlu G; Gümürdülü D; Vardar MA
    Int J Gynecol Cancer; 2016 Oct; 26(8):1480-4. PubMed ID: 27465899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer].
    Chen X; Zhang G
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):208-12. PubMed ID: 24820307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttherapy surveillance of women with cervical cancer: an outcomes analysis.
    Bodurka-Bevers D; Morris M; Eifel PJ; Levenback C; Bevers MW; Lucas KR; Wharton JT
    Gynecol Oncol; 2000 Aug; 78(2):187-93. PubMed ID: 10926801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.
    van Gent MD; van den Haak LW; Gaarenstroom KN; Peters AA; van Poelgeest MI; Trimbos JB; de Kroon CD
    Int J Gynecol Cancer; 2014 May; 24(4):735-43. PubMed ID: 24651626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.